Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

BMRNNasdaq

BIOMARIN PHARMACEUTICAL INC

Alert me on BMRN
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

5
Sep 4 Sale Davis George Eric Insider
1 week
−0.2%S&P −1.2%
1 month
−15.5%S&P +1.4%
3 months
Result in23 trading days
6 months
Result in86 trading days
May 12 Sale Friberg Gregory R Insider
1 week
−5.8%S&P −0.6%
1 month
+5.0%S&P −0.1%
3 months
+32.8%S&P +4.9%
6 months
Result in6 trading days
Mar 13 Sale Guyer Charles Greg Insider
1 week
−7.5%S&P −1.8%
1 month
−5.2%S&P +5.1%
3 months
−4.4%S&P +12.3%
6 months
+13.5%S&P +15.5%
Feb 27 Sale Friberg Gregory R Insider
1 week
−1.0%S&P −2.0%
1 month
−11.2%S&P −7.6%
3 months
−7.2%S&P +10.6%
6 months
+4.8%S&P +12.7%
Feb 27 Sale Davis George Eric Insider
1 week
−1.0%S&P −2.0%
1 month
−11.2%S&P −7.6%
3 months
−7.2%S&P +10.6%
6 months
+4.8%S&P +12.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for BMRN

41 held · newest 541 held · newest 2
Loading the filings.
See all 41 filings for BMRN

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$390KQ4 2025
$530KQ1 2026
$340KQ2 2026
$200KQ3 2026
Down 41 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.